Victrex (LON:VCT) Shares Down 8.4% - Should You Sell?

Shares of Victrex plc (LON:VCT - Get Free Report) traded down 8.4% during mid-day trading on Wednesday . The company traded as low as GBX 667.62 ($9.08) and last traded at GBX 720 ($9.79). 827,259 shares were traded during trading, an increase of 97% from the average session volume of 420,250 shares. The stock had previously closed at GBX 786 ($10.69).

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. JPMorgan Chase & Co. lowered their target price on Victrex from GBX 940 ($12.78) to GBX 818 ($11.12) and set a "neutral" rating for the company in a report on Wednesday. Deutsche Bank Aktiengesellschaft cut Victrex to a "hold" rating and lowered their target price for the stock from GBX 990 ($13.46) to GBX 850 ($11.56) in a report on Tuesday.

Victrex Stock Performance

The company has a market capitalization of £627.20 million, a price-to-earnings ratio of 20.43, a P/E/G ratio of 1.92 and a beta of 0.69. The stock's 50 day moving average price is GBX 800.54 and its 200 day moving average price is GBX 894.36. The company has a current ratio of 4.39, a quick ratio of 1.99 and a debt-to-equity ratio of 10.93.

Victrex (LON:VCT - Get Free Report) last issued its earnings results on Monday, May 12th. The company reported GBX 22.60 ($0.31) earnings per share (EPS) for the quarter. Victrex had a net margin of 10.81% and a return on equity of 6.67%. Analysts expect that Victrex plc will post 73.1078905 earnings per share for the current year.

Insider Activity at Victrex

In other Victrex news, insider Dame Vivienne Cox bought 2,747 shares of the stock in a transaction dated Tuesday, July 8th. The shares were bought at an average cost of GBX 721 ($9.80) per share, with a total value of £19,805.87 ($26,924.78). Also, insider David Thomas acquired 1,158 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The stock was purchased at an average cost of GBX 846 ($11.50) per share, for a total transaction of £9,796.68 ($13,317.94). 1.64% of the stock is currently owned by company insiders.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.